M. Morel

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Marie-angèle M Morel, Marie Angele Morel, Marie-angle Morel, Marie‐angèle M. Morel, Marie-angèle Morel, Marie-angèle M. Morel, Marie‐angele Morel, Marie-angele M Morel, Marie A Morel, M A Morel, Marie-angele Morel, Marie-angéle Morel, M Morel, Marie Angèle Morel, M. A. Morel, Marie-angel Morel, Marie‐angèle Morel, M A Morèl, Marie-angele M. Morel
Publication record
154 papers · 30,024 citations · H-index 54

PAPERS

High-risk plaques in proximal and distal segments relative to graft anastomoses and non-grafted segments.
20250 citationsauthor #22
Coronary angiography: a review of the state of the art and the evolution of angiography in cardio therapeutics
202415 citationsauthor #11
TCT-300 FFRCT-Derived Coronary Physiological Pattern and Graft Patency in the FASTTRACK CABG Trial
20240 citationsauthor #21
Coronary bypass surgery guided by computed tomography in a low-risk population
202430 citationsauthor #22
TCT-515 Myocardial Blood Flow Distribution Derived From CCTA, Myocardium at Risk, and Revascularization Completeness in FASTTRACK CABG
20241 citationsauthor #21
Cardiac computed tomography-derived coronary artery volume to myocardial mass in patients with severe coronary artery disease.
20241 citationsauthor #23
Appropriateness of the modality of revascularization according to the SYNTAX Score II 2020 in the FASTTRACK CABG study: An interim report on patient selection.
20234 citationsauthor #7
The ability of computed tomography angiography to predict 5-year mortality in the SYNTAX III REVOLUTION trial.
20234 citationsauthor #13
What Did I Learn in the 10 Years of SYNTAX? – Closing an Era of Clinical Research After Having Identified New Trial Targets With Machine Learning?
20230 citationsauthor #7
A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels.
202393 citationsauthor #19
TCT-289 Concordance of Heart Team Plannings and Actual Treatment of Coronary Surgery Based on Invasive and Noninvasive Coronary Angiography
20230 citationsauthor #19
Interim prediction of two-year all-cause mortality in patients with de novo multivessel coronary artery disease undergoing intended multivessel PCI
20230 citationsauthor #3
TCT-292 Regional Disparity of the Bypass Strategy and Graft Patent Rate in the First-in-Man Trial of Coronary Surgical Revascularization Solely Guided on Multislice Computed Tomography
20230 citationsauthor #20
TCT-290 Relationship Between Cardiac Computed Tomography-Derived Coronary Artery Volume and Myocardial Mass in Severe Coronary Artery Disease Population
20230 citationsauthor #14
10 Years of SYNTAX
202312 citationsauthor #8
CCTA-based CABG SYNTAX Score: a tool to evaluate completeness of coronary segment revascularization after bypass surgery
20233 citationsauthor #10
CRT-100.97 What Did I Learn in the 10 Years of SYNTAX? – Closing an Era of Clinical Research After Having Identified New Trial Targets With Machine Learning?
20230 citationsauthor #7
Treatment recommendation based on SYNTAX score 2020 derived from coronary computed tomography angiography and invasive coronary angiography
20236 citationsauthor #8
TCT-262 Screening Selection According to the SYNTAX Score 2020 in the FASTTRACK CABG—A First in Man Study—Assessing the Feasibility and Safety of Sole MSCT Guidance for CABG Performance
20220 citationsauthor #5
Impact of coronary calcification assessed by coronary CT angiography on treatment decision in patients with three-vessel CAD: insights from SYNTAX III trial
20216 citationsauthor #13
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease
202141 citationsauthor #16
Successful coronary artery bypass grafting based solely on non-invasive coronary computed tomography angiography.
20216 citationsauthor #5
TCT-109 Ten-Year All-Cause Death After Percutaneous or Surgical Revascularization in Diabetic Patients With Complex Coronary Artery Disease
20211 citationsauthor #11
Differential impact of abluminal groove‐filled biodegradable‐polymer sirolimus‐eluting stent versus durable‐polymer everolimus‐eluting stent on and off dual antiplatelet therapy
20211 citationsauthor #7
The SYNTAX score on its way out or … towards artificial intelligence: part I.
202029 citationsauthor #9
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.
20202 citationsauthor #9
The SYNTAX score on its way out or … towards artificial intelligence: part II.
202022 citationsauthor #9
Site vs. core laboratory variability in computed tomographic angiography-derived SYNTAX scores in the SYNTAX III trial.
20202 citationsauthor #15
A randomized controlled trial to compare the safety and efficacy of sirolimus-eluting biodegradable polymer ultra-thin stent (SUPRAFLEX Cruz) and everolimus-eluting biodegradable polymer stent (SYNERGY) in treatment for three-vessel coronary artery disease: design of the Multivessel TALENT trial.
20203 citationsauthor #7
Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.
201917 citationsauthor #7
2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.
201918 citationsauthor #7
Clinical outcomes of complex lesions treated with an abluminal groove‐filled biodegradable polymer sirolimus‐eluting stent and durable polymer everolimus‐eluting stent
20191 citationsauthor #7
A prospective multicenter randomized all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the TALENT trial.
20196 citationsauthor #14
Angiographic late lumen loss revisited: impact on long-term target lesion revascularization
201840 citationsauthor #10
A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance Imaging.
201841 citationsauthor #10
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
2018513 citationsauthor #8
Visual estimation versus different quantitative coronary angiography methods to assess lesion severity in bifurcation lesions
201815 citationsauthor #9
Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD.
2018113 citationsauthor #19
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
2018485 citationsauthor #8
TCT-360 Assessment of Heart Team’s Treatment Decision Variability: Insights from the SYNTAX III Revolution trial.
20182 citationsauthor #10
TCT-391 Post-implantation Shear Stress Analysis: An Emerging Tool for Differentiation in Bioresorbable Scaffolds
20180 citationsauthor #11
TCT-675 Site versus Core Laboratory SYNTAX score variability
20180 citationsauthor #12
TCT-191 Impact of post-procedural minimal stent area by IVUS on 2-year outcome after PCI in the SYNTAX II trial.
20180 citationsauthor #30
Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease
2018219 citationsauthor #21
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.
201850 citationsauthor #7
TCT-221 Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial
20171 citationsauthor #4
Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials.
20176 citationsauthor #7
Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial.
201731 citationsauthor #12
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
2017265 citationsauthor #33
Quantitative assessment of prosthetic valve regurgitation after TAVI by angiography and cardiac magnetic resonance imaging
20170 citationsauthor #10
Integration of non-invasive functional assessments with anatomical risk stratification in complex coronary artery disease: the non-invasive functional SYNTAX score.
201723 citationsauthor #4
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.
201627 citationsauthor #14
Tools and Techniques - Clinical: SYNTAX score II calculator.
201617 citationsauthor #4
TCT-210: Low Incidence of Stent Thrombosis in Asian Races: Multicenter Registry in Asia 6 Years Follow-Up Result
20160 citationsauthor #9
Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5,433 patients enrolled in contemporary coronary stent trials.
201533 citationsauthor #13
REASONABLE REVASCULARIZATION AFTER PERCUTANEOUS CORONARY INTERVENTION: VALIDATION OF THE SYNTAX REVASCULARIZATION INDEX FROM THE SYNTAX TRIAL
20152 citationsauthor #7
Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention.
201537 citationsauthor #7
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: An analysis of the SYNTAX Study
201544 citationsauthor #14
Inter-core lab variability in analyzing quantitative coronary angiography for bifurcation lesions: a post-hoc analysis of a randomized trial.
201539 citationsauthor #7
Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents
2015145 citationsauthor #6
Comparison between two‐ and three‐dimensional quantitative coronary angiography bifurcation analyses for the assessment of bifurcation lesions: A subanalysis of the TRYTON pivotal IDE coronary bifurcation trial
201514 citationsauthor #7
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus: Insights From a Patient-Level Pooled Analysis of SYNTAX, RESOLUTE, and LEADERS Trials
201513 citationsauthor #7
Implications of a bioresorbable vascular scaffold implantation on vessel wall strain of the treated and the adjacent segments
20143 citationsauthor #6
Response to letter regarding article, "Quantification of incomplete revascularization and its association with five-year mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial: validation of the residual SYNTAX Score".
20143 citationsauthor #13
Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry.
201470 citationsauthor #7
Predicting 3-year mortality after percutaneous coronary intervention: updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials.
201448 citationsauthor #8
PROGNOSTIC IMPLICATIONS OF SEVERE LESION CALCIFICATION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
20140 citationsauthor #12
Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trial.
201458 citationsauthor #10
Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials
2014317 citationsauthor #12
Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score
2013363 citationsauthor #13
Advanced three-dimensional quantitative coronary angiographic assessment of bifurcation lesions: methodology and phantom validation.
201346 citationsauthor #7
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.
2013769 citationsauthor #15
Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
201317 citationsauthor #12
The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.
2013295 citationsauthor #16
The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy.
201378 citationsauthor #5
Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial.
201368 citationsauthor #12
PREDICTION OF ONE-YEAR MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PCI FROM THE ACUITY (ACUTE CATHETERIZATION AND URGENT INTERVENTION TRIAGE STRATEGY) TRIAL VALIDATION OF THE LOGISTIC CLINICAL SYNTAX SCORE
20130 citationsauthor #9
Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
201361 citationsauthor #9
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
201354 citationsauthor #9
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.
20131,637 citationsauthor #9
The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy.
201313 citationsauthor #5
CT-SYNTAX score: a feasibility and reproducibility Study.
201352 citationsauthor #7
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
2012132 citationsauthor #13
TCT-40 Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND Single-arm Trial
20120 citationsauthor #5
Validity and variability in visual assessment of stenosis severity in phantom bifurcation lesions: A survey in experts during the fifth meeting of the european bifurcation club
201236 citationsauthor #4
Advances in two-dimensional quantitative coronary angiographic assessment of bifurcation lesions: improved small lumen diameter detection and automatic reference vessel diameter derivation.
201219 citationsauthor #6
COMBINED ANATOMICAL AND CLINICAL FACTORS FOR THE RISK STRATIFICATION OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: THE LOGISTIC CLINICAL SYNTAX SCORE
20123 citationsauthor #8
Relationship between palpography and virtual histology in patients with acute coronary syndromes.
201224 citationsauthor #20
A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
201298 citationsauthor #17
TCT-78 Long-Term (4-Year) Clinical Outcomes of Total Occlusions and Completeness of Revascularisation in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Trial
20120 citationsauthor #16
Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.
2012148 citationsauthor #8
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation.
20121,778 citationsauthor #40
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial.
201125 citationsauthor #5
Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS).
201139 citationsauthor #7
A novel dedicated 3-dimensional quantitative coronary analysis methodology for bifurcation lesions.
201132 citationsauthor #7
Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial
2011140 citationsauthor #6
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.
201154 citationsauthor #14
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
2011723 citationsauthor #11
SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial.
2011161 citationsauthor #5
and outcome? Does angiography six months after coronary intervention influence management
20110 citationsauthor #7

TIMELINE

1992 68 citations

1993 4 citations

1994 4,680 citations

1996 802 citations

1997 63 citations

1998 749 citations

1999 274 citations

2000 149 citations

2001 1,579 citations

2002 224 citations

2005 2,336 citations

2006 606 citations

2007 5,723 citations

2008 202 citations

2009 890 citations

2010 1,843 citations

2011 1,174 citations

2012 2,238 citations

2013 3,453 citations

2014 499 citations

2015 327 citations

2016 44 citations

2017 326 citations

2018 1,478 citations

2019 42 citations

2020 58 citations

2021 55 citations

2022 0 citations

2023 122 citations

2024 47 citations

2025 0 citations

M. Morel

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT